FlavoLife was founded by a dedicated team of leading scientists and visionary entrepreneurs, united by a shared passion for the science of aging and a commitment to developing senolytic therapeutics that empower people to live longer, healthier lives.
By blending their expertise and insights, they have created a dynamic hub of innovation, driving groundbreaking advancements in the field.
Our team excels at seamlessly connecting commercial vision with R&D expertise, ensuring that every step of drug development aligns with market needs and scientific innovation.
In a world where countless age-related diseases demand attention, we focus on identifying the most impactful opportunities.
By strategically prioritizing research areas, we channel our efforts to develop superior senolytic products that address the diseases where senescent cells play a significant pathogenic role.
With this approach, we don’t just create solutions, we pave the way for a healthier future.
CEO
Paolo has worked for over 15 years in the management consulting sector, holding the positions of Senior Principal at EVERSANA. He has successfully led the development and execution of numerous global launches of pharmaceutical products and medical devices.
Medical Innovation Officer
Clinical Officer
Business Development